LDLR and atherosclerosis: FEN treatment in LDLR−/− mice lead to a striking four-fold increase in hepatic Smpd3 expression, the gene encoding neutral sphingomyelinase-2, recently shown to contribute to the development of atherosclerosis in ApoE−/− mice.